Newport Beach, CALIFORNIA1 Active Studies

Moderate-to-Severe Asthma Clinical Trials in Newport Beach, CALIFORNIA

Find 1 actively recruiting moderate-to-severe asthma clinical trials in Newport Beach, CALIFORNIA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
250
Enrolling

Recruiting Moderate-to-Severe Asthma Studies in Newport Beach

About Moderate-to-Severe Asthma Clinical Trials in Newport Beach

Moderate-to-severe asthma affects patients whose symptoms are not adequately controlled with standard inhaled therapies. It accounts for 5-10% of asthma patients but drives a disproportionate share of healthcare costs. Biologic therapies targeting specific inflammatory pathways have transformed management.

There are currently 1 moderate-to-severe asthma clinical trials recruiting participants in Newport Beach, CALIFORNIA. These studies are seeking a combined 250 participants. Research is being sponsored by Regeneron Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.

Moderate-to-Severe Asthma Clinical Trials in Newport Beach — FAQ

Are there moderate-to-severe asthma clinical trials in Newport Beach?

Yes, there are 1 moderate-to-severe asthma clinical trials currently recruiting in Newport Beach, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newport Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newport Beach research site will contact you about next steps.

Are clinical trials in Newport Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newport Beach studies also compensate for your time and travel.

What moderate-to-severe asthma treatments are being tested?

The 1 active trials in Newport Beach are testing new therapies including novel drugs, biologics, and treatment approaches for moderate-to-severe asthma.

Data updated March 2, 2026 from ClinicalTrials.gov